Home / Research / Product codes / JWY Medical-device intelligence
JWY: Manual Antimicrobial Susceptibility Test Systems FDA product code JWY: Manual Antimicrobial Susceptibility Test Systems. View classification details, related manufacturers, 510(k) clearances, and recall records.
Classification details
Product code JWY
FDA device name Manual Antimicrobial Susceptibility Test Systems
Device class 2
Regulation number 866.1640
Medical specialty Microbiology
Review panel MI The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.
Explore microbiology records → A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.
Record activity in this scope 441 clearance records and 78 recall records in the covered releases, across 52 source company names and 1 product codes. Dated history runs from Feb 10, 1981 to Apr 21, 2026.
Monthly counts through October 2026 Month 510(k) decisions Recall initiations October 2025 1 0 November 2025 0 0 December 2025 0 0 January 2026 0 0 February 2026 0 0 March 2026 0 0 April 2026 2 0 May 2026 0 0 June 2026 0 0 July 2026 0 0 August 2026 0 0 September 2026 0 0 October 2026 0 0
Product codes represented All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.
Clearances and recall records 519 matching records Device / record Company in FDA record Source Source date ETEST Gepotidacin (GEP) (0.016-256 µg/mL) K260447 · JWYbioMérieux SA 510(k) Apr 21, 2026FDA decision date MTS Gepotidacin 0.016-256 µg/mL K260696 · JWYLiofilchem s.r.l. 510(k) Apr 17, 2026FDA decision date MTS Aztreonam-Avibactam 0.016/4 - 256/4 µg/mL K252114 · JWYLiofilchem s.r.l. 510(k) Oct 2, 2025FDA decision date The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Colistin in the dilution range of 0.12-16 ug/mL K252062 · JWYThermo Fisher Scientific 510(k) Sep 25, 2025FDA decision date The Sensititre 18 - 24 hour MIC or Breakpoint Susceptibility System with Aztreonam/avibactam in the dilution range of 0.008/4 - 64/4 ug/mL K250575 · JWYThermo Fisher Scientific 510(k) Sep 5, 2025FDA decision date The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Amikacin in the dilution range of 0.25-256 ug/mL K252014 · JWYThermo Fisher Scientific 510(k) Aug 28, 2025FDA decision date MTS Sulbactam-Durlobactam 0.004/4 - 64/4 µg/mL (SUD) K251580 · JWYLiofilchem s.r.l. 510(k) Aug 20, 2025FDA decision date The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Ciprofloxacin in the dilution range of 0.002-64 ug/mL K250990 · JWYThermo Fisher Scientific 510(k) Jun 30, 2025FDA decision date The Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with Ceftobiprole in the d… K242843 · JWYThermo Fisher Scientific 510(k) Jun 20, 2025FDA decision date ETEST Aztreonam/Avibactam (AZA) (0.016/4-256/4 µg/mL) K250856 · JWYBiomérieux 510(k) Jun 12, 2025FDA decision date Thermo SCIENTIFIC Sensititre Cation Adjusted AutoRead Mueller-Hinton Broth w/ TES w/ Lysed Horse Blood, REF CP11410; invitro diagnostic device Z-1947-2025 · JWYRemel, Inc Recall Jun 11, 2025FDA classification date The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Vancomycin in the dilution range of 0.25-128 ug/mL K242659 · JWYThermo Fisher Scientific 510(k) May 22, 2025FDA decision date ETEST Imipenem/Relebactam P. aeruginosa (IRPA) (0.008/4-128/4 µg/mL) K250274 · JWYBiomerieux S.A. 510(k) Apr 30, 2025FDA decision date The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Moxifloxacin in the dilution range of 0.008-16 ug/mL K242658 · JWYThermo Fisher Scientific 510(k) Apr 15, 2025FDA decision date The Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with Linezolid in the dilu… K242905 · JWYThermo Fisher Scientific 510(k) Feb 10, 2025FDA decision date The Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with penicillin in the dil… K243201 · JWYThermo Fisher Scientific 510(k) Feb 10, 2025FDA decision date MTS Ceftobiprole 0.002-32 µg/mL K243202 · JWYLiofilchem s.r.l. 510(k) Jan 30, 2025FDA decision date The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Ceftobiprole in the dilution range of 0.008-16 ug/mL K243169 · JWYThermo Fisher Scientific 510(k) Dec 19, 2024FDA decision date The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Linezolid in the dilution range of 0.25-32 ug/mL K242653 · JWYThermo Fisher Scientific 510(k) Dec 5, 2024FDA decision date The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Daptomycin in the dilution range of 0.03-64 ug/mL K242657 · JWYThermo Fisher Scientific 510(k) Nov 26, 2024FDA decision date The Sensititre 20 - 24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with Meropenem in the di… K242021 · JWYThermo Fisher Scientific 510(k) Oct 9, 2024FDA decision date The Sensititre 20 - 24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with ceftriaxone in the … K241967 · JWYThermo Fisher Scientific 510(k) Oct 1, 2024FDA decision date The Sensititre 20 - 24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with Imipenem in the dil… K240445 · JWYThermo Fisher Scientific 510(k) May 16, 2024FDA decision date Sensititre 20-24 hour Haemophilus influenzaelStreptococcus pneumoniae MIC or Breakpoint Susceptibility System with Ceftolozane-tazobactam in the … K232310 · JWYThermo Fisher Scientific 510(k) Oct 31, 2023FDA decision date ETEST® Sulbactam/Durlobactam (SUD) (0.004/4-64/4 µg/mL), ETEST® SUD K232395 · JWYBiomérieux 510(k) Oct 5, 2023FDA decision date
Manufacturers in these records Device classifications FDA dataset: Nov 9, 2026
Last successful check: Nov 21, 2026
Source classifications may change.
510(k) clearances FDA dataset: Nov 9, 2026
Last successful check: Nov 21, 2026
FDA publishes this dataset monthly.
Recall records FDA dataset: Nov 19, 2026
Last successful check: Nov 21, 2026
FDA publishes this dataset weekly.
Keep this research moving. Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.
Start a 14-day free trial ↗